Skip to main navigation Skip to search Skip to main content

Phase II Multi-Center Double-Blind Placebo-Controlled Randomized Parellel Group Dose Ranging Study of the Saftey and Efficacy and Tolerability of an Oral Formulation of CP-529-414 Administerred Once a Day for 8 Weeks to Subjects with Modera

  • Weinstock, Ruth (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date12/18/01 → 12/17/03

Funding

  • Pfizer Pharmaceuticals: $13,992.00